Warning letter
A & L Laboratories: warning letter of Jun 30, 2000
FDA warning letter UCM068566 · Minneapolis District Office
Key facts
| Reference number | UCM068566 |
|---|---|
| Company | A & L Laboratories |
| Subject | Good Manufacturing Practices for Finished Pharmaceuticals/Veterinary Drug Manufacturing Facility |
| Issue date | Jun 30, 2000 |
| Posted date | Jun 30, 2000 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 2, 21, 211, 211.25(a), 211.80(a), 211.84(d) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: